Rodolfo Savica

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc High school football and risk of neurodegeneration: a community-based study
    Rodolfo Savica
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 87:335-40. 2012
  2. doi Parkinsonism and dropped head: dystonia, myopathy or both?
    Rodolfo Savica
    Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Parkinsonism Relat Disord 18:30-4. 2012
  3. doi Prevention of dementia
    Rodolfo Savica
    Department of Neurology, Mayo Clinic, Gonda 8 South, 200 First Street SW, Rochester, MN 55905, USA
    Psychiatr Clin North Am 34:127-45. 2011
  4. doi Incidence of dementia with Lewy bodies and Parkinson disease dementia
    Rodolfo Savica
    Department of Neurology, College of Medicine, Mayo Clinic, Rochester, Minnesota2Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, Minnesota
    JAMA Neurol 70:1396-402. 2013
  5. pmc The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome
    Anahita Adeli
    a Department of Neurology, Mayo Clinic, Rochester, Minnesota
    Neurocase 20:110-20. 2014
  6. pmc Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism
    Rodolfo Savica
    Division of Epidemiology, Department of Health Science Research, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    JAMA Neurol 70:859-66. 2013
  7. pmc Risk factors for Parkinson's disease may differ in men and women: an exploratory study
    Rodolfo Savica
    Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Horm Behav 63:308-14. 2013
  8. pmc Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study
    Michelle M Mielke
    From the Divisions of Epidemiology M M Mielke, R O R, R C P, Y E G and Biomedical Statistics and Informatics H J W, S D W, Department of Health Sciences Research Departments of Neurology R S, D S K, R O R, R C P, Psychiatry and Psychology M M Machulda, and Radiology P V, V J L, C R J, Mayo Clinic, Rochester, MN and Departments of Psychiatry, Psychology, and Neurology Y E G, Mayo Clinic, Scottsdale, AZ
    Neurology 82:70-6. 2014
  9. ncbi Deep brain stimulation in benign tremulous parkinsonism
    Rodolfo Savica
    Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Arch Neurol 68:1033-6. 2011
  10. pmc Deep brain stimulation in tourette syndrome: a description of 3 patients with excellent outcome
    Rodolfo Savica
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 87:59-62. 2012

Detail Information

Publications15

  1. pmc High school football and risk of neurodegeneration: a community-based study
    Rodolfo Savica
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 87:335-40. 2012
    ..To assess whether high school football played between 1946 and 1956, when headgear was less protective than today, was associated with development of neurodegenerative diseases later in life...
  2. doi Parkinsonism and dropped head: dystonia, myopathy or both?
    Rodolfo Savica
    Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Parkinsonism Relat Disord 18:30-4. 2012
    ..The substrate for DHS is controversial, with some concluding that the cause is myopathic and others, exclusively dystonic. We report our clinical series of DHS arising in the setting of parkinsonism...
  3. doi Prevention of dementia
    Rodolfo Savica
    Department of Neurology, Mayo Clinic, Gonda 8 South, 200 First Street SW, Rochester, MN 55905, USA
    Psychiatr Clin North Am 34:127-45. 2011
    ....
  4. doi Incidence of dementia with Lewy bodies and Parkinson disease dementia
    Rodolfo Savica
    Department of Neurology, College of Medicine, Mayo Clinic, Rochester, Minnesota2Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, Minnesota
    JAMA Neurol 70:1396-402. 2013
    ..Epidemiologic data on dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD) remain limited in the United States and worldwide. These data are essential to guide research and clinical or public health interventions...
  5. pmc The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome
    Anahita Adeli
    a Department of Neurology, Mayo Clinic, Rochester, Minnesota
    Neurocase 20:110-20. 2014
    ....
  6. pmc Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism
    Rodolfo Savica
    Division of Epidemiology, Department of Health Science Research, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    JAMA Neurol 70:859-66. 2013
    ..The frequency and distribution of synucleinopathies and tauopathies manifesting with parkinsonism in the general population are poorly understood, thus affecting health care planning and research...
  7. pmc Risk factors for Parkinson's disease may differ in men and women: an exploratory study
    Rodolfo Savica
    Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Horm Behav 63:308-14. 2013
    ..By contrast, in women, anemia was the most important factor and we observed a suggestive synergistic interaction between anemia and higher education. Risk factors for PD and their interactions may differ in men and women...
  8. pmc Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study
    Michelle M Mielke
    From the Divisions of Epidemiology M M Mielke, R O R, R C P, Y E G and Biomedical Statistics and Informatics H J W, S D W, Department of Health Sciences Research Departments of Neurology R S, D S K, R O R, R C P, Psychiatry and Psychology M M Machulda, and Radiology P V, V J L, C R J, Mayo Clinic, Rochester, MN and Departments of Psychiatry, Psychology, and Neurology Y E G, Mayo Clinic, Scottsdale, AZ
    Neurology 82:70-6. 2014
    ..We determined whether head trauma was associated with amyloid deposition and neurodegeneration among individuals who were cognitively normal (CN) or had mild cognitive impairment (MCI)...
  9. ncbi Deep brain stimulation in benign tremulous parkinsonism
    Rodolfo Savica
    Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Arch Neurol 68:1033-6. 2011
    ..This disorder has an uncertain pathophysiologic relationship to idiopathic Parkinson disease. Deep brain stimulation (DBS) should be efficacious for this condition, but there is no previously published experience...
  10. pmc Deep brain stimulation in tourette syndrome: a description of 3 patients with excellent outcome
    Rodolfo Savica
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 87:59-62. 2012
    ..At 1-year follow-up, the mean reduction in the total Yale Global Tic Severity Scale score in the 3 patients was 70% (range, 60%-80%).Our study further supports the role of the CM/Pf DBS target in medically intractable TS...
  11. pmc Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study
    Michelle M Mielke
    Departments of Health Science Research and Neurology, Mayo Clinic, Rochester, Minnesota, United States of America
    PLoS ONE 8:e73094. 2013
    ..We hypothesized that plasma levels of lipids involved in ceramide metabolism would also be altered in PD non-GBA mutation carriers and associated with worse cognition...
  12. doi Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion
    Elizabeth A Coon
    Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Amyotroph Lateral Scler Frontotemporal Degener 14:132-7. 2013
    ..In conclusion, this kindred demonstrates that the presentation of ALS within c9FTD/ALS families may vary considerably and electrophysiologic findings reflect this heterogeneity...
  13. pmc Metabolic markers or conditions preceding Parkinson's disease: a case-control study
    Rodolfo Savica
    Department of Neurology, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Mov Disord 27:974-9. 2012
    ..77; 95% CI, 0.37-1.57; P = .47). Our study, based on historical information from a records-linkage system, does not support an association between BMI, cholesterol level, hypertension, or diabetes mellitus with later development of PD...
  14. doi Clinical failure of botulinum toxin A in movement disorders
    Rodolfo Savica
    Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Parkinsonism Relat Disord 18:73-5. 2012
    ..Botulinum toxin (BTX) injections have been used extensively in medicine; however, little is known about the factors predicting the loss of effectiveness of botulin toxin...
  15. doi Ifosfamide associated myoclonus-encephalopathy syndrome
    Rodolfo Savica
    Department of Neurology, Division of Movement Disorders, Mayo Clinic, 200 1st Street S W, Rochester, MN 55905, USA
    J Neurol 258:1729-31. 2011
    ..Treatment with methylene blue may be further considered as useful to ameliorate the movement disorders...